Kopran Limited (NSE:KOPRAN)
India · Delayed Price · Currency is INR 164.00
-3.25 (-1.94%)
May 22, 2026, 3:29 PM IST
Kopran Market Cap
Kopran has a market cap or net worth of 7.88 billion as of May 22, 2026. Its market cap has decreased by -14.06% in one year.
Market Cap
7.88B
Enterprise Value
9.33B
Revenue
6.82B
Ranking
n/a
PE Ratio
30.63
Stock Price
164.00
Market Cap Chart
Since April 1, 2002, Kopran's market cap has increased from 572.00M to 7.88B, an increase of 1,277.66%. That is a compound annual growth rate of 11.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 7.88B | 8.87% |
| Dec 31, 2025 | 7.24B | -29.34% |
| Dec 31, 2024 | 10.24B | -11.98% |
| Dec 29, 2023 | 11.64B | 60.08% |
| Dec 30, 2022 | 7.27B | -48.06% |
| Dec 31, 2021 | 14.00B | 132.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.54T |
| Divi's Laboratories | 1.83T |
| Apollo Hospitals Enterprise | 1.20T |
| Cipla | 1.13T |
| Tarsons Products | 11.64B |
| GPT Healthcare | 11.49B |
| Remus Pharmaceuticals | 9.38B |
| Accent Microcell | 8.91B |